Bill > A04604

This bill creates a wholesale prescription drug importation program that allows New York to import prescription drugs from Canada, with the goal of generating significant cost savings for consumers. The program would enable approved prescription drug wholesalers to import drugs from Canadian suppliers, subject to strict federal and state safety regulations. Specifically, the imported drugs must meet FDA safety standards, be expected to generate substantial consumer savings, and cannot include controlled substances, biological products, or certain specialized medical drugs like infused or intravenous medications. Approved wholesalers must comply with federal tracking and tracing requirements, can only sell imported drugs within New York, and must provide detailed information about each imported drug to state authorities. The program requires approval from federal health agencies, and the commissioner of health must consult with the education department to design and implement the program. The bill includes provisions for annual reporting, program auditing, and the potential suspension of drug importation if any violations are discovered. Wholesalers must obtain prior approval from the state education department to participate, pay an application fee, and renew their approvals on a schedule set by the department. The program will take effect 18 months after becoming law, allowing time for regulatory preparation and federal approvals.

Budget and Finance, Education

https://www.nysenate.gov/legislation/bills/2025/A4604